DNA Nanobots
Business Services · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1476 Manning Pkwy, Powell, Ohio, 43065, ...Phone Number
(614) 325-2103Website
www.dnananobots.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About DNA Nanobots
DNA Nanobots is a privately held biotechnology company focused on developing the next generation of targeted nanomedicines. Utilizing precise DNA self-assembly (DNA origami), the company engineers nanobots designed to carry and release therapeutic payloads directly to diseased cells with unprecedented specificity, minimizing systemic toxicity, and maximizing treatment efficacy. DNA Nanobots deliver genes that are considered undeliverable. DNA Nanobots; reshaping gene therapy.Explore more
DNA Nanobots Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DNA Nanobots your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on DNA Nanobots recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at DNA Nanobots
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if DNA Nanobots has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when DNA Nanobots launches new products
DNA Nanobots, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once DNA Nanobots has new funding data
Click to see if DNA Nanobots had a recent Job posting/layoffs
Check out if DNA Nanobots is spiking on competitors!
Recommended Actions
Find VP level buyers at DNA Nanobots
Find more new buyers
Compare Similar Companies to DNA Nanobots
Compare insights from companies similar to DNA Nanobots, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
DNA Nanobots is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DNA Nanobots is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DNA Nanobots.
DNA Nanobots financials insights
Gather financial insights about DNA Nanobots, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Seed
$3.5M
DNA Nanobots Tech Stack
A closer look at the technologies used by DNA Nanobots
See more technologies
Most Recent Scoops
Funding
Funding
Person-Based
Facilities Relocation / Expansion
DNA Nanobots is planning to move offices in January 2026. The move will impact approximately 6 employees at the existing office located at 1476 Manning Pkwy, Powell, OH.
Facilities Relocation/Expansion
Funding
DNA Nanobots News & Media
DNA Nanobots Secures $3.5 Million Seed Funding
POWELL, OH, DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, announced it has secured $3.5 million in seed funding.DNA Nanobots Adds John C. Byrd, M.D. to Scientific Advisory Board to Help Guide Its Next Generation DNA Nanoparticle Targeted Drug Delivery Platform
COLUMBUS, Ohio--(BUSINESS WIRE)--DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced today that Dr. John C. Byrd, M.D., has joined its scientific advisory board (SAB). Byrd is an internationally recognized physician scientist who played significant roles in the translational research and development of several impactful new therapies in blood cell cancers. Byrd has collaborated with DNA Nanobots founding scientists for over 10 years and willDNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
COLUMBUS, Ohio--(BUSINESS WIRE)-- #Nanobots--DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, today announced that it completed exclusive commercial licensing of a gene editing technology from the University of California (UC) Berkeley. The licensed intellectual property enables ‘folding’ of genes into their own delivery devices, together with CRISPR-Cas and proximal homology directed repair (HDR) arms for highly efficient non-viral gene delivery. SDestroy Duchenne selects DNA Nanobots as Partner to Develop Non-Viral Gene Delivery Solution for Duchenne Muscular Dystrophy
NORCO, Calif. & COLUMBUS, Ohio--(BUSINESS WIRE)-- #DNA--DNA Nanobots was Selected by Destroy Duchenne to Develop a Targeted Non-Viral Gene Delivery Solution for Duchenne Muscular Dystrophy.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding DNA Nanobots
Sign Up For FreeTo access detailed company insights
DNA Nanobots is a privately held biotechnology company focused on developing the next generation of targeted nanomedicines. Utilizing precise DNA self-assembly (DNA origami), the company engineers nanobots designed to carry and release therapeutic payloads directly to diseased cells with unprecedented specificity, minimizing systemic toxicity, and... Read More
